382 related articles for article (PubMed ID: 32884319)
1. Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.
Freitas E; Rodrigues MA; Torres T
Clin Cosmet Investig Dermatol; 2020; 13():561-578. PubMed ID: 32884319
[TBL] [Abstract][Full Text] [Related]
2. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
3. Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
Burden AD; Bissonnette R; Navarini AA; Murakami M; Morita A; Haeufel T; Ye B; Baehner F; Terui T
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2279-2297. PubMed ID: 37731086
[TBL] [Abstract][Full Text] [Related]
4. An update on therapeutic options for palmoplantar pustulosis: a narrative review and expert recommendations.
Xu JM; Wang HM; Jin HZ
Expert Rev Clin Immunol; 2023 May; 19(5):499-516. PubMed ID: 36970858
[TBL] [Abstract][Full Text] [Related]
5. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
Yamamoto T
Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in palmoplantar pustulosis.
Brunasso AMG; Massone C
Fac Rev; 2021; 10():62. PubMed ID: 34409425
[TBL] [Abstract][Full Text] [Related]
7. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.
Misiak-Galazka M; Zozula J; Rudnicka L
Am J Clin Dermatol; 2020 Jun; 21(3):355-370. PubMed ID: 32008176
[TBL] [Abstract][Full Text] [Related]
8. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study.
Mrowietz U; Burden AD; Pinter A; Reich K; Schäkel K; Baum P; Datsenko Y; Deng H; Padula SJ; Thoma C; Bissonnette R
Dermatol Ther (Heidelb); 2021 Apr; 11(2):571-585. PubMed ID: 33661508
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of biological agents to treat patients with palmoplantar pustulosis: A systematic scoping review.
Zhang M; Hua L; Hong S; Sun X; Zhou Y; Luo Y; Liu L; Wang J; Wang C; Lin N; Li X
Int Immunopharmacol; 2023 Sep; 122():110553. PubMed ID: 37480749
[TBL] [Abstract][Full Text] [Related]
10. Interventions for chronic palmoplantar pustulosis.
Marsland AM; Chalmers RJ; Hollis S; Leonardi-Bee J; Griffiths CE
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001433. PubMed ID: 16437433
[TBL] [Abstract][Full Text] [Related]
11. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
Murakami M; Terui T
J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
[TBL] [Abstract][Full Text] [Related]
12. Cigarette Smoke Underlies the Pathogenesis of Palmoplantar Pustulosis via an IL-17A-Induced Production of IL-36γ in Tonsillar Epithelial Cells.
Kobayashi K; Kamekura R; Kato J; Kamiya S; Kamiya T; Takano K; Ichimiya S; Uhara H
J Invest Dermatol; 2021 Jun; 141(6):1533-1541.e4. PubMed ID: 33188781
[TBL] [Abstract][Full Text] [Related]
13. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.
Heidemeyer K; May Lee M; Cazzaniga S; Yawalkar N; Naldi L
Psoriasis (Auckl); 2023; 13():33-58. PubMed ID: 37772169
[TBL] [Abstract][Full Text] [Related]
14. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
Yamamoto T
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
[TBL] [Abstract][Full Text] [Related]
15. What do we know about palmoplantar pustulosis?
Misiak-Galazka M; Wolska H; Rudnicka L
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
[TBL] [Abstract][Full Text] [Related]
16. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
Xu Q; Wang X; Yang A; Wei G
Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
[TBL] [Abstract][Full Text] [Related]
17. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for palmoplantar pustulosis.
Adişen E; Gürer MA
Clin Exp Dermatol; 2010 Apr; 35(3):219-22. PubMed ID: 19874337
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
Sanchez IM; Sorenson E; Levin E; Liao W
Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
Yamamoto T
Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
